copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Metastatic Castration-Sensitive Prostate Cancer: Optimizing Patient . . . The Role of Localized Therapy in Metastatic Castration-sensitive Prostate Cancer Prostate radiation or radical prostatectomy (RP) are not currently recommended for the treatment of patients with de novo metastatic prostate cancer
Advances in the Treatment and Management of Metastatic Castration . . . Metastatic castration-sensitive prostate cancer (mCSPC), also referred to as metastatic hormone-sensitive prostate cancer (mHSPC), is an advanced form of prostate cancer defined by disease that has spread from the prostate into other regions of the body and that remains responsive to hormone therapy 10 It can further be subdivided according to
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer The initial treatment for metastatic prostate cancer is androgen-deprivation therapy (ADT) through medical or surgical castration In the past few years, results from several large, randomized
Treatment for Metastatic Prostate Cancer Often Suboptimal In most people with metastatic hormone-sensitive prostate cancer, the cancer eventually changes so that it can grow without being reliant on testosterone from the testes, known as hormone-resistant (or castration-resistant) disease
Emerging Evidence-Based Treatment Strategies in Metastatic Castration . . . Patients with Metastatic Castration-Resistant Prostate Cancer Today: Unmet Needs and Treatment Goals Rana McKay McKay opened this symposium by describing the natural history of mCRPC Among patients experiencing disease recurrence after definitive treatment of localised prostate cancer, some may progress to metastatic disease while the cancer remains hormone sensitive (mHSPC) and later become
How We Treat Metastatic Castration-Sensitive Prostate Cancer Risk Stratifying Metastatic Castration-Sensitive Prostate Cancer Among the numerous available strategies, the best choice of first-line therapy for mCSPC is a contentious matter, primarily due to the remarkably variable clinical course of this disease state
Treating Metastatic Castrate-sensitive Prostate Cancer . . . - AUANews Figure Treatment algorithm ADT indicates androgen deprivation therapy; mCSPC, metastatic castrate-sensitive prostate cancer; XRT, radiation therapy Despite a reduction in the overall incidence, the 2004-2018 SEER (Surveillance, Epidemiology, and End Results) data reveal a concerning trend of increase in the incidence of metastatic prostate